APPLICATION OF CERULOPLASMIN IN TREATMENT OF PATIENTS WITH HEPATITIS
In the world, for every 7 seconds from diabetes, one person dies, because of diabetic lesions, more than 1 million amputations of the lower extremities are produced per year. Therefore, the search for new drugs and the treatment of diabetic patients in Kyrgyzstan is an urgent task. It is shown that the use of ceruloplasmin leads to rapid normalization of patients with viral hepatitis B of medium severity. The efficacy and prospects of ceruloplasmin are indicated not only in the treatment of acute viral hepatitis, but also in the treatment of drug addicts and in their reduction in drug dependence.